動物用医薬品配合市場：製品、形態、投与、動物、エンドユーザー別-2025～2030年世界予測

動物用医薬品配合市場は、2023年に11億9,000万米ドルと評価され、2024年には12億8,000万米ドルに達すると予測され、CAGR 9.98％で成長し、2030年には23億3,000万米ドルになると予測されています。

動物用医薬品配合とは、市販の医薬品では不十分な場合に、特定のニーズや状況に合わせて動物用にカスタマイズ型医薬品を調製することを指します。動物の大きさ、種類、特定の健康上のニーズは様々であり、標準的な薬剤では対応できない場合があるため、このような慣行が必要となります。例えば、馬のような大型の動物は、猫や犬のような小型の動物とは異なる用量を必要とする場合があり、また、特定の製剤や香料にアレルギー反応を示す動物もいます。主要用途としては、投薬量の変更、投薬形態の変更（錠剤から液体への変更など）、薬剤をより嗜好性の高いものにするための香料の添加などが挙げられます。最終用途は動物病院、動物病院、家畜管理施設などです。市場の成長は、世界のペット飼育の増加、動物の慢性疾患の増加、動物医療におけるより個別化された医療の必要性から影響を受けています。さらに、医薬製剤の進歩により、より正確で効果的な配合薬が可能になり、さらなる需要を牽引しています。現在のビジネス機会には、動物医療が成長している新興市場への進出や、より正確な処方のための技術の活用などがあります。しかし、FDAのような機関による規制のハードルや、厳格な品質管理基準の維持など、成長を阻害しかねない課題も残っています。様々な生物種に対する医薬品の安全性と有効性を確保することの複雑さが、市場拡大をさらに複雑にしています。技術革新は、より効率的な調合プロセスの構築、環境に優しく安全な製剤の開発、より正確な投薬のためのデジタルツールの活用などを中心に展開することができます。代替配合材料や不正開封防止包装の調査も競争優位性をもたらす可能性があります。研究開発のために獣医療機関と共同パートナーシップを結ぶことで、重要な洞察が得られ、市場の裾野が広がる可能性があります。最終的には、個別化された動物ケアと世界の拡大戦略に焦点を当てることが、市場のリーダーにとって極めて重要であることが証明されるであると考えられます。

市場力学：急速に進化する動物用医薬品配合市場の主要市場洞察を公開

動物用医薬品配合市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また消費者行動や、それが製造コストや購買傾向に与える影響についてもより明確に理解することができます。

ポーターの5つの力：動物用医薬品配合市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用医薬品配合市場における外部からの影響の把握

外部マクロ環境要因は、動物用医薬品配合市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用医薬品配合市場における競合情勢の把握

動物用医薬品配合市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス動物用医薬品配合市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用医薬品配合市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用医薬品配合市場における成功への道筋を描く

動物用医薬品配合市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度：現在の市場環境についての詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存セクターにおける拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを調査します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行えるよう、重要な質問にも回答しています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットの飼育数が世界的に増加し、ペットオーナーがペットにお金を使う意欲も高まっている
    • ペットの慢性疾患の増加と特定の薬の必要性
    • 世界中で獣医クリニックと薬局を拡大
  • 抑制要因
    • 調合プロセスの複雑さと熟練した人員の必要性
  • 機会
    • 獣医薬理学の革新とドラッグデリバリー技術の進歩
    • 動物病院、ペット保険会社、研究機関との戦略的提携の構築
  • 課題
    • 動物用医薬品配合の安全性と有効性に関する懸念
• 市場セグメンテーション分析
  • 製品：炎症性疾患の蔓延に対応する抗炎症剤の必要性
  • エンドユーザー：獣医クリニックや病院で治療される幅広い種と多種多様な病状
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 動物用医薬品配合市場：製品別

• イントロダクション
• 抗感染剤
• 抗炎症剤
• 中枢神経系（CNS）薬
• 胃腸薬

第7章 動物用医薬品配合市場：形態別

• イントロダクション
• カプセル
• クリーム＆ジェル
• 軟膏
• 懸濁液

第8章 動物用医薬品配合市場：投与別

• イントロダクション
• 注射
• 経口
• 局所

第9章 動物用医薬品配合市場：動物別

• イントロダクション
• コンパニオンアニマル
• 大型動物
• 家畜

第10章 動物用医薬品配合市場：エンドユーザー別

• イントロダクション
• 牛の飼育
• ペットの飼い主
• 養鶏業
• 動物クリニックと病院

第11章 南北アメリカの動物用医薬品配合市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋の動物用医薬品配合市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの動物用医薬品配合市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • SurescriptsとDAW Systemsの戦略的提携により、獣医の電子処方が強化され、ペットケアにおける効率と服薬遵守が向上
  • MixlabがVanterra Venturesの支援を受けてNexGen Animal Healthを買収し、大型動物への調合サービスを拡大
  • Veterinary Pharmaceutical Solutions、Diamond Animal Healthの買収により市場での地位を強化
• 戦略分析と提言

企業一覧

• 1. Akina Animal Health
• 2. Aurora Compounding Pharmacy
• 3. Caringbah Compounding Pharmacy
• 4. Central Compounding Center South
• 5. Chiron Compounding Pharmacy, Inc
• 6. Custom-Med Compounding Pharmacy
• 7. Davis Islands Pharmacy
• 8. Dougherty's Pharmacy, Inc
• 9. Hoye's Pharmacy
• 10. Medisca Inc.
• 11. MEDS Canadian Compounding Pharmacy
• 12. Millers Pharmacy
• 13. Pace Pharmacy
• 14. People's Choice of Pharmacy
• 15. Pratt's Compounding Pharmacy
• 16. Sixth Avenue Medical Pharmacy
• 17. Smith Caldwell Drug Store by Walgreen Co.
• 18. Specialist Compounding Pharmacy Pte Ltd
• 19. Tache Pharmacy & Medical Supplies
• 20. Triangle Compounding Pharmacy
• 21. Vertisis Custom Pharmacy
• 22. Victoria Compounding Pharmacy
• 23. Vimian Group AB
• 24. Wedgewood Pharmacy
• 25. Wellness Pharmacy of Cary

LIST OF FIGURES

• FIGURE 1. ANIMAL DRUG COMPOUNDING MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL DRUG COMPOUNDING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ANIMAL DRUG COMPOUNDING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. ANIMAL DRUG COMPOUNDING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL DRUG COMPOUNDING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL DRUG COMPOUNDING MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANTI-INFECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM (CNS) AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY GASTRO-INTESTINAL(GI) DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CREAMS & GELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY CATTLE REARING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY POULTRY BUSINESSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 48. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 50. CANADA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 75. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 77. CHINA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 80. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 82. INDIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 166. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 168. ITALY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 186. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 188. POLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 191. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 193. QATAR ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM ANIMAL DRUG COMPOUNDING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. ANIMAL DRUG COMPOUNDING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 240. ANIMAL DRUG COMPOUNDING MARKET, FPNV POSITIONING MATRIX, 2023

The Animal Drug Compounding Market was valued at USD 1.19 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 9.98%, to USD 2.33 billion by 2030.

Animal drug compounding refers to the customized preparation of medications for animals, tailored to specific needs and circumstances when commercially available drugs do not suffice. This practice is necessary due to the varied sizes, species, and specific health needs of animals, which standard forms of medication may not fulfill. For instance, large animals like horses may require a different dose compared to smaller animals such as cats or dogs, and some animals may have allergic reactions to certain formulations or flavors. The primary applications include altering drug dosages, changing medication formats (such as from a pill to a liquid), and adding flavors to make medications more palatable. End-use scopes encompass veterinary clinics, animal hospitals, and livestock management facilities. Market growth is influenced by the increasing pet ownership globally, the rise of chronic diseases in animals, and the need for more personalized medicine in veterinary care. Moreover, advancements in pharmaceutical formulations have enabled more precise and effective compounded drugs, driving further demand. Current opportunities include expanding into emerging markets where veterinary health care is growing, and leveraging technology for more accurate formulations. However, challenges persist, including regulatory hurdles imposed by agencies like the FDA and maintaining stringent quality control standards, which can inhibit growth. The complexity of ensuring drug safety and efficacy for varied species further complicates market expansion. Innovations can revolve around creating more efficient compounding processes, developing eco-friendly and safe formulations, and utilizing digital tools for better dosage accuracy. Research into alternative compounding materials and tamper-proof packaging may also offer competitive advantages. Entering collaborative partnerships with veterinary institutions for research and development could provide critical insights and broaden the market reach. Ultimately, a focus on personalized animal care and global expansion strategies could prove pivotal for market leaders.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Drug Compounding Market

The Animal Drug Compounding Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in pet ownership globally, coupled with the growing willingness of pet owners to spend on their pets
  • Increase in chronic conditions in pets and need for specific medications
  • Expansion of veterinary clinics and pharmacies across the world
• Market Restraints
  • Complexities in the compounding process and the need for skilled personnel
• Market Opportunities
  • Innovations in veterinary pharmacology and advancements in drug delivery technologies
  • Establishment of strategic alliances with veterinary clinics, animal hospitals, pet insurance companies, and research institutions
• Market Challenges
  • Concerns related to the safety and efficacy of animal drug compounding

Porter's Five Forces: A Strategic Tool for Navigating the Animal Drug Compounding Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Drug Compounding Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Drug Compounding Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Drug Compounding Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Drug Compounding Market

A detailed market share analysis in the Animal Drug Compounding Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Drug Compounding Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Drug Compounding Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Drug Compounding Market

A strategic analysis of the Animal Drug Compounding Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Drug Compounding Market, highlighting leading vendors and their innovative profiles. These include Akina Animal Health, Aurora Compounding Pharmacy, Caringbah Compounding Pharmacy, Central Compounding Center South, Chiron Compounding Pharmacy, Inc, Custom-Med Compounding Pharmacy, Davis Islands Pharmacy, Dougherty's Pharmacy, Inc, Hoye's Pharmacy, Medisca Inc., MEDS Canadian Compounding Pharmacy, Millers Pharmacy, Pace Pharmacy, People's Choice of Pharmacy, Pratt's Compounding Pharmacy, Sixth Avenue Medical Pharmacy, Smith Caldwell Drug Store by Walgreen Co., Specialist Compounding Pharmacy Pte Ltd, Tache Pharmacy & Medical Supplies, Triangle Compounding Pharmacy, Vertisis Custom Pharmacy, Victoria Compounding Pharmacy, Vimian Group AB, Wedgewood Pharmacy, and Wellness Pharmacy of Cary.

Market Segmentation & Coverage

This research report categorizes the Animal Drug Compounding Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Anti-Infective Agents, Anti-Inflammatory Agents, Central Nervous System (CNS) Agents, and Gastro-Intestinal(GI) Drugs.
• Based on Form, market is studied across Capsules, Creams & Gels, Ointments, and Suspension.
• Based on Administration, market is studied across Injectable, Oral, and Topical.
• Based on Animal, market is studied across Companion Animals, Large Animals, and Livestock Animals.
• Based on End-User, market is studied across Cattle Rearing, Pet Owners, Poultry Businesses, and Veterinary Clinics & Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in pet ownership globally, coupled with the growing willingness of pet owners to spend on their pets
    • 5.1.1.2. Increase in chronic conditions in pets and need for specific medications
    • 5.1.1.3. Expansion of veterinary clinics and pharmacies across the world
  • 5.1.2. Restraints
    • 5.1.2.1. Complexities in the compounding process and the need for skilled personnel
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in veterinary pharmacology and advancements in drug delivery technologies
    • 5.1.3.2. Establishment of strategic alliances with veterinary clinics, animal hospitals, pet insurance companies, and research institutions
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to the safety and efficacy of animal drug compounding
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Need for anti-inflammatory agents to cater to the high prevalence of inflammatory conditions
  • 5.2.2. End-User: Extensive range of species and wide variety of medical conditions treated in veterinary clinics and hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Drug Compounding Market, by Product

• 6.1. Introduction
• 6.2. Anti-Infective Agents
• 6.3. Anti-Inflammatory Agents
• 6.4. Central Nervous System (CNS) Agents
• 6.5. Gastro-Intestinal(GI) Drugs

7. Animal Drug Compounding Market, by Form

• 7.1. Introduction
• 7.2. Capsules
• 7.3. Creams & Gels
• 7.4. Ointments
• 7.5. Suspension

8. Animal Drug Compounding Market, by Administration

• 8.1. Introduction
• 8.2. Injectable
• 8.3. Oral
• 8.4. Topical

9. Animal Drug Compounding Market, by Animal

• 9.1. Introduction
• 9.2. Companion Animals
• 9.3. Large Animals
• 9.4. Livestock Animals

10. Animal Drug Compounding Market, by End-User

• 10.1. Introduction
• 10.2. Cattle Rearing
• 10.3. Pet Owners
• 10.4. Poultry Businesses
• 10.5. Veterinary Clinics & Hospitals

11. Americas Animal Drug Compounding Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Animal Drug Compounding Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Animal Drug Compounding Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Strategic Partnership Between Surescripts and DAW Systems Enhances Veterinary e-Prescribing, Boosts Efficiency and Medication Adherence in Pet Care
  • 14.3.2. Mixlab Acquires NexGen Animal Health to Expand Compounding Services to Large Animals with Vanterra Ventures' Backing
  • 14.3.3. Veterinary Pharmaceutical Solutions Strengthens Market Position with Acquisition of Diamond Animal Health
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Akina Animal Health
• 2. Aurora Compounding Pharmacy
• 3. Caringbah Compounding Pharmacy
• 4. Central Compounding Center South
• 5. Chiron Compounding Pharmacy, Inc
• 6. Custom-Med Compounding Pharmacy
• 7. Davis Islands Pharmacy
• 8. Dougherty's Pharmacy, Inc
• 9. Hoye's Pharmacy
• 10. Medisca Inc.
• 11. MEDS Canadian Compounding Pharmacy
• 12. Millers Pharmacy
• 13. Pace Pharmacy
• 14. People's Choice of Pharmacy
• 15. Pratt's Compounding Pharmacy
• 16. Sixth Avenue Medical Pharmacy
• 17. Smith Caldwell Drug Store by Walgreen Co.
• 18. Specialist Compounding Pharmacy Pte Ltd
• 19. Tache Pharmacy & Medical Supplies
• 20. Triangle Compounding Pharmacy
• 21. Vertisis Custom Pharmacy
• 22. Victoria Compounding Pharmacy
• 23. Vimian Group AB
• 24. Wedgewood Pharmacy
• 25. Wellness Pharmacy of Cary